McIlrath & Eck, LLC

SEC CIK: 0001701714
Latest filing: May 19, 2026

SEC filings (opens in a new tab)

SRPT holding history

Sarepta Therapeutics, Inc. in every 13F filed by McIlrath & Eck, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SRPT overview All 13F holders of SRPT Full Q1 2026 holdings

Shares (Q2 2023): 0; Sold out in Q2 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2021

Holdings of SRPT by McIlrath & Eck, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2023	0	$0	0.0%	−5−100.0%	Sold out	Holders
Q1 2023	5	$689	<0.1%	+5	New	Holders
Q2 2021	0	$0	0.0%	−7−100.0%	Sold out	Holders
Q1 2021	7	$1.00K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.